|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 57.30 EUR | +0.44% |
|
+1.96% | -7.58% |
| 07-09 | Verbund Wins European Commission Approval for EWE Hydrogen JV | MT |
| 05-21 | Berenberg Cuts Price Target, Forecasts for Verbund on Generation, Tax Headwinds | MT |
| Fiscal Period: December | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
Profitability | ||||||||||
Return on Assets | 4.9 | 9.23 | 12.71 | 9.47 | 7.06 | |||||
Return on Total Capital | 7.94 | 15.16 | 18.75 | 13.2 | 9.65 | |||||
Return On Equity % | 14.96 | 26.54 | 27.96 | 19.2 | 15.12 | |||||
Return on Common Equity | 15.04 | 26.96 | 26.28 | 18.8 | 14.66 | |||||
Margin Analysis | ||||||||||
Gross Profit Margin % | 40.2 | 29.28 | 45.87 | 51.66 | 47.66 | |||||
SG&A Margin | 8.35 | 4.14 | 4.9 | 6.97 | 7.62 | |||||
EBITDA Margin % | 31.92 | 30.34 | 42.54 | 41.87 | 33.8 | |||||
EBITA Margin % | 24.08 | 26.13 | 37.74 | 35.37 | 26.63 | |||||
EBIT Margin % | 23.82 | 25.97 | 37.53 | 35.06 | 26.24 | |||||
Income From Continuing Operations Margin % | 20.58 | 18.82 | 26.09 | 25.91 | 21.08 | |||||
Net Income Margin % | 18.25 | 16.58 | 21.64 | 22.71 | 18.54 | |||||
Net Avail. For Common Margin % | 18.25 | 16.58 | 21.64 | 22.71 | 18.54 | |||||
Normalized Net Income Margin | 12.85 | 13.51 | 19.32 | 19.01 | 13.89 | |||||
Levered Free Cash Flow Margin | 17.12 | -4.24 | 15.93 | 16.53 | 2.31 | |||||
Unlevered Free Cash Flow Margin | 18.13 | -3.63 | 16.67 | 17.47 | 3.19 | |||||
Asset Turnover | ||||||||||
Asset Turnover | 0.33 | 0.57 | 0.54 | 0.43 | 0.43 | |||||
Fixed Assets Turnover | 0.47 | 0.91 | 0.84 | 0.63 | 0.59 | |||||
Receivables Turnover (Average Receivables) | 7.87 | 11.26 | 10.45 | 8.64 | 9.44 | |||||
Inventory Turnover (Average Inventory) | 69.02 | 84.72 | 55.63 | 45.61 | 49.4 | |||||
Short Term Liquidity | ||||||||||
Current Ratio | 0.67 | 0.94 | 1.14 | 1.41 | 0.98 | |||||
Quick Ratio | 0.19 | 0.35 | 0.65 | 1.08 | 0.66 | |||||
Operating Cash Flow to Current Liabilities | 0.02 | 0.49 | 1.61 | 1.83 | 1.09 | |||||
Days Sales Outstanding (Average Receivables) | 46.39 | 32.43 | 34.92 | 42.37 | 38.68 | |||||
Days Outstanding Inventory (Average Inventory) | 5.29 | 4.31 | 6.56 | 8.02 | 7.39 | |||||
Average Days Payable Outstanding | 32.8 | 17.42 | 24.01 | 31.9 | 30.21 | |||||
Cash Conversion Cycle (Average Days) | 18.87 | 19.31 | 17.47 | 18.49 | 15.86 | |||||
Long Term Solvency | ||||||||||
Total Debt/Equity | 53.38 | 49.15 | 22.89 | 22.71 | 21.71 | |||||
Total Debt / Total Capital | 34.8 | 32.95 | 18.63 | 18.5 | 17.84 | |||||
LT Debt/Equity | 30.18 | 35.69 | 15.18 | 20.68 | 17.2 | |||||
Long-Term Debt / Total Capital | 19.67 | 23.93 | 12.35 | 16.85 | 14.13 | |||||
Total Liabilities / Total Assets | 62.81 | 56.55 | 42.41 | 40.89 | 39.11 | |||||
EBIT / Interest Expense | 14.66 | 26.45 | 31.47 | 23.13 | 18.6 | |||||
EBITDA / Interest Expense | 20.02 | 31 | 35.77 | 27.75 | 24.12 | |||||
(EBITDA - Capex) / Interest Expense | 9.04 | 20.27 | 24.57 | 18.66 | 12.04 | |||||
Total Debt / EBITDA | 2.18 | 1.3 | 0.57 | 0.72 | 0.9 | |||||
Net Debt / EBITDA | 1.97 | 1.17 | 0.36 | 0.47 | 0.85 | |||||
Total Debt / (EBITDA - Capex) | 4.83 | 1.98 | 0.84 | 1.08 | 1.8 | |||||
Net Debt / (EBITDA - Capex) | 4.37 | 1.79 | 0.52 | 0.7 | 1.7 | |||||
Growth Over Prior Year | ||||||||||
Total Revenues, 1 Yr. Growth % | 38.49 | 116.35 | 1.1 | -21.13 | -2.72 | |||||
Gross Profit, 1 Yr. Growth % | -2.48 | 57.58 | 58.35 | -11.18 | -10.25 | |||||
EBITDA, 1 Yr. Growth % | 21.75 | 105.67 | 42.18 | -22.69 | -21.48 | |||||
EBITA, 1 Yr. Growth % | 25.25 | 134.78 | 46.53 | -26.43 | -26.77 | |||||
EBIT, 1 Yr. Growth % | 25.08 | 135.86 | 46.65 | -26.66 | -27.19 | |||||
Earnings From Cont. Operations, 1 Yr. Growth % | 38.85 | 97.83 | 40.2 | -21.68 | -20.86 | |||||
Net Income, 1 Yr. Growth % | 38.35 | 96.55 | 31.98 | -17.25 | -20.58 | |||||
Diluted EPS Before Extra, 1 Yr. Growth % | 38.35 | 96.55 | 31.98 | -17.25 | -20.58 | |||||
Normalized Net Income, 1 Yr. Growth % | 26.69 | 127.53 | 44.76 | -22.68 | -28.9 | |||||
Net Property, Plant and Equip., 1 Yr. Growth % | 13.21 | 11.57 | 7.02 | 3.08 | 6 | |||||
Inventory, 1 Yr. Growth % | 51.1 | 146.4 | -34.33 | 16.74 | -19.49 | |||||
Accounts Receivable, 1 Yr. Growth % | 138.83 | 18.35 | 0.35 | -10.91 | -12.47 | |||||
Total Assets, 1 Yr. Growth % | 42.74 | 10.85 | 1.72 | -3.94 | -0.58 | |||||
Tangible Book Value, 1 Yr. Growth % | -14.78 | 29.07 | 48.71 | -1.08 | 4.28 | |||||
Cash From Operations, 1 Yr. Growth % | -91.7 | 1.96K | 151.65 | -36.09 | -40.94 | |||||
Capital Expenditures, 1 Yr. Growth % | 41.78 | 27.77 | 28.16 | -18.66 | 20.29 | |||||
Levered Free Cash Flow, 1 Yr. Growth % | 36.59 | -153.95 | -478.29 | -20.98 | -86.94 | |||||
Unlevered Free Cash Flow, 1 Yr. Growth % | 33.44 | -143.54 | -557.4 | -20.56 | -82.9 | |||||
Dividend Per Share, 1 Yr. Growth % | 40 | 132.38 | 39.34 | -17.65 | -28.57 | |||||
Common Equity, 1 Yr. Growth % | -11.21 | 33.22 | 37.01 | 0.08 | 3.64 | |||||
Compound Annual Growth Rate Over Two Years | ||||||||||
Total Revenues, 2 Yr. CAGR % | 10.71 | 73.1 | 47.89 | -10.71 | -12.41 | |||||
Gross Profit, 2 Yr. CAGR % | 6.33 | 23.97 | 57.96 | 18.6 | -10.71 | |||||
EBITDA, 2 Yr. CAGR % | 15.36 | 58.24 | 70.74 | 5.06 | -22.09 | |||||
EBITA, 2 Yr. CAGR % | 18.13 | 71.48 | 85.14 | 4.07 | -26.6 | |||||
EBIT, 2 Yr. CAGR % | 18.03 | 71.76 | 85.64 | 3.95 | -26.93 | |||||
Earnings From Cont. Operations, 2 Yr. CAGR % | 24 | 65.74 | 66.54 | 4.78 | -21.27 | |||||
Net Income, 2 Yr. CAGR % | 25.48 | 64.9 | 61.06 | 4.51 | -18.93 | |||||
Diluted EPS Before Extra, 2 Yr. CAGR % | 25.48 | 64.9 | 61.06 | 4.51 | -18.93 | |||||
Normalized Net Income, 2 Yr. CAGR % | 26.89 | 69.78 | 81.32 | 5.98 | -25.85 | |||||
Net Property, Plant and Equip., 2 Yr. CAGR % | 7.97 | 12.39 | 9.28 | 5.04 | 4.53 | |||||
Inventory, 2 Yr. CAGR % | 20.6 | 92.95 | 27.2 | -12.45 | -3.05 | |||||
Accounts Receivable, 2 Yr. CAGR % | 51.24 | 68.12 | 8.98 | -5.44 | -11.69 | |||||
Total Assets, 2 Yr. CAGR % | 20.22 | 26.41 | 6.19 | -1.15 | -2.27 | |||||
Common Equity, 2 Yr. CAGR % | -3.69 | 8.76 | 35.1 | 17.1 | 1.85 | |||||
Tangible Book Value, 2 Yr. CAGR % | -5.53 | 4.88 | 38.54 | 21.29 | 1.57 | |||||
Cash From Operations, 2 Yr. CAGR % | -71.45 | 30.71 | 619.59 | 26.82 | -38.56 | |||||
Capital Expenditures, 2 Yr. CAGR % | 47.76 | 34.6 | 27.97 | 2.1 | -1.09 | |||||
Levered Free Cash Flow, 2 Yr. CAGR % | 54.7 | -14.44 | 43.13 | 75.94 | -67.2 | |||||
Unlevered Free Cash Flow, 2 Yr. CAGR % | 45.26 | -24.01 | 42.25 | 94.43 | -62.41 | |||||
Dividend Per Share, 2 Yr. CAGR % | 23.36 | 80.37 | 79.95 | 7.12 | -23.3 | |||||
Compound Annual Growth Rate Over Three Years | ||||||||||
Total Revenues, 3 Yr. CAGR % | 21.33 | 38.42 | 44.69 | 19.93 | -8.12 | |||||
Gross Profit, 3 Yr. CAGR % | 11.99 | 21.23 | 34.51 | 30.38 | 8.08 | |||||
EBITDA, 3 Yr. CAGR % | 21.04 | 39.88 | 52.54 | 31.29 | -4.66 | |||||
EBITA, 3 Yr. CAGR % | 28.65 | 48.52 | 62.53 | 36.33 | -7.44 | |||||
EBIT, 3 Yr. CAGR % | 28.74 | 48.67 | 62.75 | 36.43 | -7.69 | |||||
Earnings From Cont. Operations, 3 Yr. CAGR % | 27.41 | 44.89 | 56.74 | 29.51 | -4.57 | |||||
Net Income, 3 Yr. CAGR % | 26.34 | 45.73 | 53.1 | 29 | -4.63 | |||||
Diluted EPS Before Extra, 3 Yr. CAGR % | 26.34 | 45.73 | 53.1 | 29 | -4.63 | |||||
Normalized Net Income, 3 Yr. CAGR % | 33.34 | 54.15 | 60.9 | 36.64 | -7.22 | |||||
Net Property, Plant and Equip., 3 Yr. CAGR % | 6.36 | 9.16 | 10.57 | 7.17 | 5.36 | |||||
Inventory, 3 Yr. CAGR % | 11.55 | 53.03 | 34.72 | 23.61 | -14.86 | |||||
Accounts Receivable, 3 Yr. CAGR % | 27.56 | 39.37 | 41.55 | 1.9 | -7.84 | |||||
Total Assets, 3 Yr. CAGR % | 13.49 | 17.4 | 17.58 | 2.7 | -0.96 | |||||
Common Equity, 3 Yr. CAGR % | 0.97 | 7.31 | 17.46 | 22.25 | 12.43 | |||||
Tangible Book Value, 3 Yr. CAGR % | 0.08 | 4.83 | 17.83 | 23.83 | 15.33 | |||||
Cash From Operations, 3 Yr. CAGR % | -47.13 | 18.81 | 62.61 | 221.06 | -1.7 | |||||
Capital Expenditures, 3 Yr. CAGR % | 42.43 | 40.77 | 32.42 | 10.03 | 7.83 | |||||
Levered Free Cash Flow, 3 Yr. CAGR % | 51.22 | 8.65 | 40.61 | 18.79 | -25.03 | |||||
Unlevered Free Cash Flow, 3 Yr. CAGR % | 39.96 | -2.99 | 38.97 | 18.7 | -12.4 | |||||
Dividend Per Share, 3 Yr. CAGR % | 35.72 | 52.35 | 65.5 | 38.67 | -6.41 | |||||
Compound Annual Growth Rate Over Five Years | ||||||||||
Total Revenues, 5 Yr. CAGR % | 11.27 | 28.85 | 31.33 | 16.15 | 18.37 | |||||
Gross Profit, 5 Yr. CAGR % | 6.32 | 17.17 | 28.5 | 20.17 | 14.17 | |||||
EBITDA, 5 Yr. CAGR % | 10.64 | 28.64 | 38.89 | 24.67 | 16.69 | |||||
EBITA, 5 Yr. CAGR % | 14.37 | 37.19 | 48.82 | 28.73 | 18.37 | |||||
EBIT, 5 Yr. CAGR % | 14.39 | 37.33 | 49.04 | 28.75 | 18.25 | |||||
Earnings From Cont. Operations, 5 Yr. CAGR % | 16.47 | 45.24 | 41.82 | 27.27 | 19.01 | |||||
Net Income, 5 Yr. CAGR % | 15.53 | 41.62 | 39.23 | 27.58 | 18.72 | |||||
Diluted EPS Before Extra, 5 Yr. CAGR % | 15.53 | 41.62 | 39.23 | 27.58 | 18.72 | |||||
Normalized Net Income, 5 Yr. CAGR % | 15.62 | 32.99 | 50.78 | 32.65 | 18.11 | |||||
Net Property, Plant and Equip., 5 Yr. CAGR % | 3.64 | 6.27 | 7.51 | 7.49 | 8.11 | |||||
Inventory, 5 Yr. CAGR % | 40.59 | 63.62 | 17.56 | 22.4 | 18.1 | |||||
Accounts Receivable, 5 Yr. CAGR % | 18.77 | 22.88 | 19.78 | 19.34 | 17.21 | |||||
Total Assets, 5 Yr. CAGR % | 8.2 | 11.17 | 10.73 | 9.6 | 9.19 | |||||
Common Equity, 5 Yr. CAGR % | 2.27 | 7.52 | 13.45 | 11.13 | 10.95 | |||||
Tangible Book Value, 5 Yr. CAGR % | 2.8 | 6.57 | 13.99 | 11.13 | 11.03 | |||||
Cash From Operations, 5 Yr. CAGR % | -34.34 | 25.82 | 50.24 | 21.95 | 10.17 | |||||
Capital Expenditures, 5 Yr. CAGR % | 28.04 | 34.99 | 36.46 | 23.8 | 17.83 | |||||
Levered Free Cash Flow, 5 Yr. CAGR % | 5.36 | 3.43 | 47.73 | 31.85 | -20.9 | |||||
Unlevered Free Cash Flow, 5 Yr. CAGR % | 3.94 | -3.64 | 40.7 | 28.53 | -16.98 | |||||
Dividend Per Share, 5 Yr. CAGR % | 29.35 | 42.18 | 51.93 | 32.33 | 21.67 |
- Stock Market
- Stocks
- VER Stock
- Financials Verbund AG
- Financial Ratios
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition















